Genscript Biotech Stock Technical Analysis
| GNNSF Stock | USD 1.75 0.20 12.90% |
As of the 28th of February, Genscript Biotech retains the Market Risk Adjusted Performance of (0.37), standard deviation of 4.48, and Risk Adjusted Performance of (0.04). Genscript Biotech technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Genscript Biotech variance and value at risk to decide if Genscript Biotech is priced fairly, providing market reflects its last-minute price of 1.75 per share. Please also validate Genscript Biotech jensen alpha, which is currently at (0.38) to confirm the company can sustain itself at a future point.
Genscript Biotech Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Genscript, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to GenscriptGenscript |
Genscript Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Genscript Biotech's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Genscript Biotech.
| 11/30/2025 |
| 02/28/2026 |
If you would invest 0.00 in Genscript Biotech on November 30, 2025 and sell it all today you would earn a total of 0.00 from holding Genscript Biotech or generate 0.0% return on investment in Genscript Biotech over 90 days. Genscript Biotech is related to or competes with Shanghai Junshi, Laboratorios Farmaceuticos, InnoCare Pharma, Camurus AB, ALK-Abelló A/S, Zealand Pharma, and Siegfried Holding. Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science resear... More
Genscript Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Genscript Biotech's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Genscript Biotech upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 25.17 | |||
| Value At Risk | (7.42) |
Genscript Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Genscript Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Genscript Biotech's standard deviation. In reality, there are many statistical measures that can use Genscript Biotech historical prices to predict the future Genscript Biotech's volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.38) | |||
| Total Risk Alpha | (0.78) | |||
| Treynor Ratio | (0.38) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Genscript Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Genscript Biotech February 28, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | (0.37) | |||
| Mean Deviation | 1.65 | |||
| Coefficient Of Variation | (1,482) | |||
| Standard Deviation | 4.48 | |||
| Variance | 20.03 | |||
| Information Ratio | (0.09) | |||
| Jensen Alpha | (0.38) | |||
| Total Risk Alpha | (0.78) | |||
| Treynor Ratio | (0.38) | |||
| Maximum Drawdown | 25.17 | |||
| Value At Risk | (7.42) | |||
| Skewness | (1.52) | |||
| Kurtosis | 10.74 |
Genscript Biotech Backtested Returns
Genscript Biotech holds Efficiency (Sharpe) Ratio of -0.069, which attests that the entity had a -0.069 % return per unit of risk over the last 3 months. Genscript Biotech exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Genscript Biotech's Standard Deviation of 4.48, risk adjusted performance of (0.04), and Market Risk Adjusted Performance of (0.37) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.81, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Genscript Biotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding Genscript Biotech is expected to be smaller as well. At this point, Genscript Biotech has a negative expected return of -0.32%. Please make sure to check out Genscript Biotech's treynor ratio, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Genscript Biotech performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.61 |
Good predictability
Genscript Biotech has good predictability. Overlapping area represents the amount of predictability between Genscript Biotech time series from 30th of November 2025 to 14th of January 2026 and 14th of January 2026 to 28th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Genscript Biotech price movement. The serial correlation of 0.61 indicates that roughly 61.0% of current Genscript Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.61 | |
| Spearman Rank Test | 0.67 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Genscript Biotech technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Genscript Biotech Technical Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Normalized Average True Range is used to analyze tradable apportunities for Genscript Biotech across different markets.
About Genscript Biotech Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Genscript Biotech on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Genscript Biotech based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Genscript Biotech price pattern first instead of the macroeconomic environment surrounding Genscript Biotech. By analyzing Genscript Biotech's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Genscript Biotech's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Genscript Biotech specific price patterns or momentum indicators. Please read more on our technical analysis page.
Genscript Biotech February 28, 2026 Technical Indicators
Most technical analysis of Genscript help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Genscript from various momentum indicators to cycle indicators. When you analyze Genscript charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | (0.37) | |||
| Mean Deviation | 1.65 | |||
| Coefficient Of Variation | (1,482) | |||
| Standard Deviation | 4.48 | |||
| Variance | 20.03 | |||
| Information Ratio | (0.09) | |||
| Jensen Alpha | (0.38) | |||
| Total Risk Alpha | (0.78) | |||
| Treynor Ratio | (0.38) | |||
| Maximum Drawdown | 25.17 | |||
| Value At Risk | (7.42) | |||
| Skewness | (1.52) | |||
| Kurtosis | 10.74 |
Genscript Biotech February 28, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Genscript stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | Huge | ||
| Rate Of Daily Change | 1.13 | ||
| Day Median Price | 1.75 | ||
| Day Typical Price | 1.75 | ||
| Price Action Indicator | 0.10 |
Complementary Tools for Genscript Pink Sheet analysis
When running Genscript Biotech's price analysis, check to measure Genscript Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genscript Biotech is operating at the current time. Most of Genscript Biotech's value examination focuses on studying past and present price action to predict the probability of Genscript Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genscript Biotech's price. Additionally, you may evaluate how the addition of Genscript Biotech to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| CEOs Directory Screen CEOs from public companies around the world | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |